These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 10864417)

  • 1. Regional distribution of histamine H3 receptor binding sites in rat brain following L-histidine loading--an autoradiography study.
    Lozeva V; Plumed C; Männistö PT; Tuomisto L
    Inflamm Res; 2000 Apr; 49 Suppl 1():S47-8. PubMed ID: 10864417
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain histamine and histamine H3 receptors following repeated L-histidine administration in rats.
    Lozeva V; Tarhanen J; Attila M; Männistö PT; Tuomisto L
    Life Sci; 2003 Aug; 73(12):1491-503. PubMed ID: 12865089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine H3 binding sites in rat brain: localization in the nucleus of the solitary tract.
    Cumming P; Gjedde A; Vincent S
    Brain Res; 1994 Apr; 641(2):198-202. PubMed ID: 8012821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.
    Ligneau X; Garbarg M; Vizuete ML; Diaz J; Purand K; Stark H; Schunack W; Schwartz JC
    J Pharmacol Exp Ther; 1994 Oct; 271(1):452-9. PubMed ID: 7965746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H3 receptor binding sites in rat cortex following L-histidine loading.
    Lozeva V; Männistö PT; Tuomisto L
    Inflamm Res; 1999 Apr; 48 Suppl 1():S59-60. PubMed ID: 10350163
    [No Abstract]   [Full Text] [Related]  

  • 6. Subclasses of histamine H3 antagonist binding sites in rat brain.
    Cumming P; Gjedde A
    Brain Res; 1994 Apr; 641(2):203-7. PubMed ID: 8012822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked increase in [3H](R) alpha-methylhistamine binding in the superior colliculus of visually deprived rats after unilateral enucleation.
    Nakagawa Y; Yanai K; Ryu JH; Kiyosawa M; Tamai M; Watanabe T
    Brain Res; 1994 Apr; 643(1-2):74-80. PubMed ID: 8032934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
    Mezzomo K; Cumming P; Minuzzi L
    Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of [125I]WYE-230949 as a novel histamine H3 receptor radiopharmaceutical.
    Lewis DY; Champion S; Wyper D; Dewar D; Pimlott S
    PLoS One; 2014; 9(12):e115876. PubMed ID: 25542008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of (R)-alpha-methylhistamine on the histamine H3 receptor in the rat gastrointestinal tract.
    Chazot P; Shenton F; Schunack W; Grandi D; Morini G
    Inflamm Res; 2007 Apr; 56 Suppl 1():S19-20. PubMed ID: 17806162
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery and Preclinical Validation of [(11)C]AZ13153556, a Novel Probe for the Histamine Type 3 Receptor.
    Schou M; Varnäs K; Jureus A; Ahlgren C; Malmquist J; Häggkvist J; Tari L; Wesolowski SS; Throner SR; Brown DG; Nilsson M; Johnström P; Finnema SJ; Nakao R; Amini N; Takano A; Farde L
    ACS Chem Neurosci; 2016 Feb; 7(2):177-84. PubMed ID: 26529287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of low level histamine H3 receptor occupancy by autoradiography.
    Le S; Finn JP; Larijani ME; Marino MJ; Schaffhauser H
    J Neurosci Methods; 2009 Dec; 185(1):70-5. PubMed ID: 19765611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studies.
    Tedford CE; Yates SL; Pawlowski GP; Nalwalk JW; Hough LB; Khan MA; Phillips JG; Durant GJ; Frederickson RC
    J Pharmacol Exp Ther; 1995 Nov; 275(2):598-604. PubMed ID: 7473144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
    Ligneau X; Lin J; Vanni-Mercier G; Jouvet M; Muir JL; Ganellin CR; Stark H; Elz S; Schunack W; Schwartz J
    J Pharmacol Exp Ther; 1998 Nov; 287(2):658-66. PubMed ID: 9808693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.
    Kovalainen JT; Christiaans JA; Kotisaari S; Laitinen JT; Männistö PT; Tuomisto L; Gynther J
    J Med Chem; 1999 Apr; 42(7):1193-202. PubMed ID: 10197963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute central administration of immepip, a histamine H3 receptor agonist, suppresses hypothalamic histamine release and elicits feeding behavior in rats.
    Chiba S; Itateyama E; Sakata T; Yoshimatsu H
    Brain Res Bull; 2009 Apr; 79(1):37-40. PubMed ID: 19150394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and functional expression of the human histamine H3 receptor.
    Lovenberg TW; Roland BL; Wilson SJ; Jiang X; Pyati J; Huvar A; Jackson MR; Erlander MG
    Mol Pharmacol; 1999 Jun; 55(6):1101-7. PubMed ID: 10347254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressed weight gain following chronic I-histidine loading--involvement of neuronal histaminergic system?
    Lensu S; Tarhanen J; Tuomisto L
    Inflamm Res; 2003 Apr; 52 Suppl 1():S35-6. PubMed ID: 12755400
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
    Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
    Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles.
    Mor M; Bordi F; Silva C; Rivara S; Crivori P; Plazzi PV; Ballabeni V; Caretta A; Barocelli E; Impicciatore M; Carrupt PA; Testa B
    J Med Chem; 1997 Aug; 40(16):2571-8. PubMed ID: 9258364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.